Literature DB >> 27424850

Hospital Distance and Readmissions Among VA-Medicare Dual-Enrolled Veterans.

Edwin S Wong1,2, Seppo T Rinne3,4, Paul L Hebert5,6, Meredith A Cook5, Chuan-Fen Liu5,6.   

Abstract

PURPOSE: Geographic access to inpatient care at the Veterans Affairs (VA) Health Care System is challenging for many veterans with chronic obstructive pulmonary disease (COPD) given relatively few VA hospitals nationwide. Veterans with lengthy travel distances may obtain non-VA care, particularly those dually enrolled in Medicare. Our primary objective was to assess whether distance from VA patients' residence to the nearest VA and non-VA hospitals was associated with 30-day all-cause readmission and the system where patients were readmitted (VA or Medicare).
METHODS: Using VA and Medicare administrative data, we identified 21,273 patients hospitalized for COPD between October 2008 and September 2011 and dually enrolled in VA and fee-for-service Medicare. Outcome variables were dichotomous measures denoting readmission for any cause within 30 days following discharge and whether the readmission occurred in a non-VA hospital through Medicare. Distance to the nearest hospital was defined as the number of miles between patients' residence ZIP code and the ZIP code of the nearest VA and non-VA hospital accepting Medicare, respectively. Probit models with sample selection were applied to examine the relationship between hospital distance and outcome measures.
FINDINGS: Respective distances to the nearest VA and non-VA hospital were not associated with 30-day all-cause readmission. Greater distance to the nearest VA hospital was associated with a greater conditional probability of choosing non-VA hospitals for readmission.
CONCLUSIONS: COPD patients with poor geographic access to VA hospitals did not forgo subsequent inpatient care following their index hospitalization, but they were more likely to seek non-VA substitutes.
© 2016 National Rural Health Association.

Entities:  

Keywords:  Medicare; access to care; econometrics; utilization of health services; veterans

Mesh:

Year:  2016        PMID: 27424850     DOI: 10.1111/jrh.12191

Source DB:  PubMed          Journal:  J Rural Health        ISSN: 0890-765X            Impact factor:   4.333


  6 in total

1.  Impact of Guideline Changes on Indications for Inhaled Corticosteroids among Veterans with Chronic Obstructive Pulmonary Disease.

Authors:  Seppo T Rinne; Renda Soylemez Wiener; Yahong Chen; Peter Rise; Edmunds Udris; Laura C Feemster; David H Au
Journal:  Am J Respir Crit Care Med       Date:  2018-11-01       Impact factor: 21.405

2.  Fee-for-Service Medicare-Enrolled Elderly Veterans Are Increasingly Voting with Their Feet to Use More VA and Less Medicare, 2003-2014.

Authors:  Chuan-Fen Liu; Adam Batten; Edwin S Wong; Stephan D Fihn; Paul L Hebert
Journal:  Health Serv Res       Date:  2018-08-27       Impact factor: 3.402

3.  Using Veterans Affairs Corporate Data Warehouse to identify 30-day hospital readmissions.

Authors:  Brenda M Vincent; Wyndy L Wiitala; Jennifer A Burns; Theodore J Iwashyna; Hallie C Prescott
Journal:  Health Serv Outcomes Res Methodol       Date:  2018-02-19

4.  Telehealth in Response to the COVID-19 Pandemic in Rural Veteran and Military Beneficiaries.

Authors:  Robert D Shura; Timothy W Brearly; Larry A Tupler
Journal:  J Rural Health       Date:  2020-05-30       Impact factor: 4.333

5.  Association Between Rural Residence and In-Hospital and 30-Day Mortality Among Veterans Hospitalized with COPD Exacerbations.

Authors:  Spyridon Fortis; Amy M J O'Shea; Brice F Beck; Alejandro Comellas; Mary Vaughan Sarrazin; Peter J Kaboli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-02

6.  Anticipating VA/non-VA care coordination demand for Veterans at high risk for hospitalization.

Authors:  Megan E Vanneman; Jean Yoon; Sara J Singer; Todd H Wagner; Mary K Goldstein; Jiaqi Hu; Derek Boothroyd; Liberty Greene; Donna M Zulman
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.